Amadeo Parissenti

Biography

1991-1995 Postdoctoral Research Fellowship in Medicine, Banting and Best Department of Medical Research, University of Toronto, Toronto, Ontario 1989-1991 Postdoctoral Research Fellow in Medicine, Harvard Medical School & Joslin Diabetes Center, Boston, Massachusetts, USA 1989 Ph.D. York University (Biochemistry), Toronto, Ontario 1983 B.Sc. University of Guelph (Biochemistry), Guelph, Ontario 1991-1995 Postdoctoral Research Fellowship in Medicine, Banting and Best Department of Medical Research, University of Toronto, Toronto, Ontario 1989-1991 Postdoctoral Research Fellow in Medicine, Harvard Medical School & Joslin Diabetes Center, Boston, Massachusetts, USA 1989 Ph.D. York University (Biochemistry), Toronto, Ontario 1983 B.Sc. University of Guelph (Biochemistry), Guelph, Ontario

Research Interest

While chemotherapy drugs are highly effective in combating the growth of tumours, resistance to these drugs typically develops during treatment, resulting in treatment failure and progression of disease. Patients then move on to other chemotherapy drugs but these drugs often also become ineffective in halting tumour growth. This phenomenon is called “multidrug resistance”. The research efforts of my research group are focused on better understanding factors that affect the response of tumours to chemotherapy drugs and how tumour cells develop resistance to chemotherapy.